ResearcherCedars-Sinai Medical CenterNo recent work listed
Tamar Rubinek
Matched on ORCID iD 0000-0003-4731-8887; OpenAlex author ID A5062850935. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 1, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 7
2011: 1 paper · 2012: none · 2013: none · 2014: none · 2015: none · 2016: none · 2017: none · 2018: 1 paper · 2019: none · 2020: none · 2021: 1 paper · 2022: 1 paper
Papers 4
- Genomic alterations drive metastases formation in pancreatic ductal adenocarcinoma cancer: deciphering the role of CDKN2A and CDKN2B in mediating liver tropism. Last author DOI 10.1038/s41388-022-02184-2↗
- A Transgenic Model Reveals the Role of Klotho in Pancreatic Cancer Development and Paves the Way for New Klotho-Based Therapy. Last author DOI 10.3390/cancers13246297↗
- New somatostatin-drug conjugates for effective targeting pancreatic cancer. Co-author DOI 10.1016/j.bmc.2018.06.032↗
- KL1 internal repeat mediates klotho tumor suppressor activities and inhibits bFGF and IGF-I signaling in pancreatic cancer. First author DOI 10.1158/1078-0432.ccr-10-2749↗
Closest collaborators
The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Ido Wolf · 4 shared papers, 2011–2022 · strength 0.35
- Paper Genomic alterations drive metastases formation in pancreatic ductal adenocarcinoma cancer: deciphering the role of CDKN… DOI 10.1038/s41388-022-02184-2↗
- Paper A Transgenic Model Reveals the Role of Klotho in Pancreatic Cancer Development and Paves the Way for New Klotho-Based T… DOI 10.3390/cancers13246297↗
- Paper New somatostatin-drug conjugates for effective targeting pancreatic cancer. DOI 10.1016/j.bmc.2018.06.032↗
- Shani Journo · 1 shared paper, 2022 · strength 0.15
- Ethan S. Sokol · 1 shared paper, 2022 · strength 0.15
- Tammi Arbel Rubinstein · 1 shared paper, 2021 · strength 0.11
- Elena Ragozin · 1 shared paper, 2018 · strength 0.07
- Gary Gellerman · 1 shared paper, 2018 · strength 0.07
- Lilach Abramovitz · 1 shared paper, 2011 · strength 0.03
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.